SCHEMBL4601615

SCHEMBL4601615

CCOC(=O)C(Cc1c[nH]c2cc(F)c(F)cc12)[N+](=O)[O-]

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 2/20 0.60
GPR84 Q9NQS5 1/20 0.43
MTNR1A P48039 3/20 0.43
HTR2B P41595 1/20 0.40
PTPRA P18433 1/20 0.38
MTNR1B P49286 2/20 0.38
NQO2 P16083 1/20 0.38
CYP2C19 P33261 1/20 0.37
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HTR1A P08908 1/20 0.36
MAPT P10636 2/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
THRB P10828 1/20 0.36
PKM P14618 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15374323 0.81 SCN9A (0.68) SCN9ACYP2C19MAPTLMNATP53
SCHEMBL17760581 0.81 SCN9A (0.57) SCN9AGPR84MTNR1AHTR2BPTPRA
SCHEMBL4601569 0.81 SCN9A (0.57) SCN9AGPR84MTNR1AHTR2BPTPRA
Hydrochloric Acid SCHEMBL4634230 0.80 SCN9A (0.56) SCN9AGPR84MTNR1AHTR2BPTPRA
SCHEMBL14464051 0.79 SCN9A (0.63) SCN9AHTR1AMAPTLMNATP53
SCHEMBL9989807 0.75 SCN9A (0.86) SCN9APTPRACYP2C19MAPTLMNA
SCHEMBL9988819 0.75 SCN9A (1.00) SCN9AMAPTLMNATP53THRB
SCHEMBL2287234 0.70 SCN9A (0.51) SCN9AHTR2BCYP2C19HTR2AHTR2C
SCHEMBL27220736 0.70 GPR84 (0.50) GPR84MTNR1AHTR2BMTNR1BCYP2C19
SCHEMBL27220732 0.70 GPR84 (0.50) GPR84MTNR1AHTR2BMTNR1BCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221195-A1 1,2-DIARYLACETYLENE DERIVATIVES OF ACYLTRYPTOPHANOLS BAYER SCHERING PHARMA AG (DE) 2008-09-11 US disclosed
US-20080207728-A1 BICYCLIC ACYLTRYPTOPHANOLS BAYER SCHERING PHARMA AG (DE) 2008-08-28 US disclosed
EP-1956016-A1 Bicyclic acyltryptophanols Bayer Schering Pharma Aktiengesellschaft (DE) 2008-08-13 EP disclosed
WO-2008071453-A1 1,2-DIARYLACETYLENE DERIVATIVES OF ACYLTRYPTOPHANOLS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-06-19 WO disclosed
WO-2008071455-A1 BICYCLIC ACYLTRYPTOPHANOLS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-06-19 WO disclosed
EP-1932831-A1 1,2-Diarylacetylene Derivatives of Acyltryptophanols Bayer Schering Pharma Aktiengesellschaft (DE) 2008-06-18 EP disclosed
EP-1912970-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL Bayer Schering Pharma Aktiengesellschaft (DE) 2008-04-23 EP disclosed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed
WO-2007017289-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-02-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221195-A1 1,2-DIARYLACETYLENE DERIVATIVES OF ACYLTRYPTOPHANOLS FSHR, GNRHR, TPH1 SCN9A 2507/4885GPR84 323/4885MTNR1A 22/4885
US-20080207728-A1 BICYCLIC ACYLTRYPTOPHANOLS FSHR, GNRHR, TPH1 SCN9A 3914/4885GPR84 304/4885MTNR1A 28/4885
US-20070060573-A1 Acyltryptophanols FSHR, NPY1R, NPY2R SCN9A 3913/4885GPR84 244/4885MTNR1A 21/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.